Ilsung Clarithromycin Tablet 500mg

Adult dosage

○ Adults: The usual dose of clarithromycin is 250mg (potency) twice daily; for severe infections, administer 500mg (potency) twice daily. The usual duration of treatment is 7～14 days. In patients with renal failure whose creatinine clearance is 30mL/min or less, the dose should be reduced by half: 250mg (potency) once daily, or, for severe infections, 250mg (potency) twice daily. Do not administer to these patients for more than 14 days. ○ Mycobacterial infections: Administer 500mg (potency) of this medicine twice daily. In this case, it should be administered concomitantly with other antimycobacterial agents such as ethambutol, clofazimine, and rifampin. ○ Eradication of Helicobacter pylori in patients with duodenal ulcers: For 14 days, administer 500mg (potency) of this medicine 3 times daily with omeprazole 40mg once daily, followed by omeprazole 40mg once daily for 14 consecutive days. That is, administer clarithromycin 500mg (potency) per dose 3 times daily for 14 days (days 1～14), and omeprazole 40mg once daily for 28 days (days 1～28).

Children's dosage

○ Children aged 12 years and older: Same as adults ○ For children under 12 years of age, use clarithromycin dry syrup.

This medication should not be used in patients who are allergic to certain ingredients or have had hypersensitivity reactions to specific antibiotic classes. Patients with heart-related diseases or significantly impaired liver and kidney function should be especially cautious when using this medication. It is advisable for pregnant or breastfeeding women to avoid taking this medication. This medication can interact with various other drugs, so it is imperative to discuss any currently taken medications with a doctor or pharmacist. If any allergic reactions or severe side effects occur during treatment, administration should be discontinued immediately and medical personnel notified. This medication may cause various side effects such as gastrointestinal disturbances, skin rashes, and central nervous system symptoms, so careful monitoring is required in case of symptom occurrence. Regular check-ups are needed as auditory abnormalities or liver dysfunction may appear with long-term or high-dose use. Dosage adjustments may be necessary for elderly patients or those with diminished kidney function. To prevent the development of antibiotic-resistant bacteria, it is important to only take this medication for the necessary duration and not to stop arbitrarily. Caution is needed as this medication may affect driving or machinery operation; if symptoms such as dizziness or confusion occur, it is essential to be careful.

Shock, anaphylactic symptoms, respiratory distress, seizures, flushing, rash, itching, hives, skin flushing, angioedema, joint swelling, drug rash, abdominal bloating, nausea, vomiting, dyspepsia, abdominal pain, malaise, flatulence, diarrhea, oral mucosal erosion, epigastric pain, thirst, transient tooth discoloration, pancreatitis, elevated amylase, dysgeusia, anorexia, constipation, discoloration of stool, pseudomembranous colitis, hemorrhagic colitis, fever, cough, abnormal chest X-ray, eosinophilia, eosinophilic pulmonary infiltrate, interstitial pneumonia, chronic bronchitis, exacerbation of acute maxillary sinusitis, eosinophilia, thrombocytopenia, pancytopenia, hemolytic anemia, leukopenia, agranulocytosis, dizziness, depression, loss of taste, loss of smell, anxiety, insomnia, nightmares, tinnitus, confusion, disorientation, hallucination, psychosis, depersonalization, seizures, tremors, numbness, behavioral changes, manic behavior, Stevens-Johnson syndrome, toxic epidermal necrolysis, allergic purpura, drug rash accompanied by eosinophilia and systemic symptoms, jaundice, hepatocellular or cholestatic hepatitis, increased liver enzymes, liver dysfunction, liver failure, fulminant hepatitis, elevated AST, elevated ALT, elevated γ-GTP, elevated LDH, elevated ALP, increased total bilirubin, increased serum creatinine, increased BUN, interstitial nephritis, renal failure, rhabdomyolysis, stomatitis, oral mucositis, oral candidiasis, QT prolongation, ventricular tachycardia, Torsades de pointes, lethargy, headache, dysgeusia, hearing loss, paresthesia, arthralgia, myalgia, olfactory dysfunction, tinnitus, auditory impairment, hypoglycemia, tinnitus, hearing impairment, vomiting, nausea, abdominal pain, purpuric rash, acute pancreatitis, increased amylase, elevated AST and ALT, leukopenia and thrombocytopenia, elevated ALT, elevated AST, elevated γ-GTP, elevated ALP, elevated LDH, increased serum creatinine, elevated blood urea nitrogen, renal failure, nephritis, injection site phlebitis, injection site pain, injection site inflammation, fever, asthenia, chest pain, chills, fatigue, albumin-globulin ratio abnormalities, elevated serum alkaline phosphatase, elevated serum lactate dehydrogenase, increased INR, prolonged prothrombin time, abnormal urine color, vasodilation, cardiac arrest, atrial fibrillation, ectopic beats, palpitations, asthma, epistaxis, pulmonary embolism, esophagitis, gastroesophageal reflux disease, gastritis, rectal pain, belching, bloating, acute generalized exanthematous pustulosis, muscle spasms, musculoskeletal rigidity, myopathy, angioedema, vasodilation

This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. It is advisable to maintain the storage temperature between 15 degrees and 30 degrees Celsius.

Appearance

Yellow, oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle